BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

526546

CHOKSILA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

CHOKSI LABORATORIES LTD. Share Price Update

As of the latest trading session, CHOKSI LABORATORIES LTD. share price is currently at ₹ 121.8, which is up by ₹ 2.70 from its previous closing. Today, the stock has fluctuated between ₹ 116.05 and ₹ 122.65. Over the past year, CHOKSI LABORATORIES LTD. has achieved a return of 75.56 %. In the last month alone, the return has been -3.17 %. Read More...

CHOKSI LABORATORIES LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    84.20

  • P/E Ratio (TTM)

    64.73

  • Beta

    0.77

  • Book Value / share

    33.03

  • Return on equity

    5.12%

  • EPS (TTM)

    1.84

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.11

info icon alternate text

CHOKSI LABORATORIES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 10.38
Operating Expense 10.20
Net Profit 0.11
Net Profit Margin (%) 1.05
Earnings Per Share (EPS) 0.15
EBITDA 2.55
Effective Tax Rate (%) 44.44
Particulars SEP 2024 (Values in Cr)
Revenue 9.26
Operating Expense 9.18
Net Profit 0.08
Net Profit Margin (%) 0.86
Earnings Per Share (EPS) 0.11
EBITDA 2.37
Effective Tax Rate (%) 20.00
Particulars JUN 2024 (Values in Cr)
Revenue 10.74
Operating Expense 10.13
Net Profit 0.42
Net Profit Margin (%) 3.91
Earnings Per Share (EPS) 0.60
EBITDA 2.84
Effective Tax Rate (%) 30.64
Particulars MAR 2024 (Values in Cr)
Revenue 11.12
Operating Expense 9.90
Net Profit 0.68
Net Profit Margin (%) 6.11
Earnings Per Share (EPS) 0.98
EBITDA 3.55
Effective Tax Rate (%) 46.51
Particulars DEC 2023 (Values in Cr)
Revenue 8.79
Operating Expense 8.65
Net Profit 0.06
Net Profit Margin (%) 0.68
Earnings Per Share (EPS) 0.09
EBITDA 2.25
Effective Tax Rate (%) 53.33
Particulars MAR 2024 (Values in Cr)
Revenue 36.70
Operating Expense 35.19
Net Profit 1.11
Net Profit Margin (%) 3.02
Earnings Per Share (EPS) 1.59
EBITDA 10.37
Effective Tax Rate (%) 33.13
Particulars MAR 2023 (Values in Cr)
Revenue 34.44
Operating Expense 33.19
Net Profit 3.21
Net Profit Margin (%) 9.32
Earnings Per Share (EPS) 4.61
EBITDA 12.71
Effective Tax Rate (%) 13.70
Particulars MAR 2022 (Values in Cr)
Revenue 30.04
Operating Expense 29.80
Net Profit 0.21
Net Profit Margin (%) 0.69
Earnings Per Share (EPS) 0.30
EBITDA 9.01
Effective Tax Rate (%) 43.24
Particulars MAR 2021 (Values in Cr)
Revenue 25.69
Operating Expense 28.98
Net Profit -2.61
Net Profit Margin (%) -10.15
Earnings Per Share (EPS) -3.74
EBITDA 4.56
Effective Tax Rate (%) 7.11
Particulars MAR 2020 (Values in Cr)
Revenue 28.16
Operating Expense 31.77
Net Profit -3.88
Net Profit Margin (%) -13.77
Earnings Per Share (EPS) -5.58
EBITDA 0.73
Effective Tax Rate (%) 32.04
Particulars MAR 2024 (Values in Cr)
Book Value / Share 31.89
ROE % 5.12
ROCE % 8.58
Total Debt to Total Equity 1.46
EBITDA Margin 28.45
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.31
ROE % 8.41
ROCE % 8.92
Total Debt to Total Equity 1.79
EBITDA Margin 30.43
Particulars MAR 2022 (Values in Cr)
Book Value / Share 25.70
ROE % 1.18
ROCE % 6.29
Total Debt to Total Equity 2.14
EBITDA Margin 30.03
Particulars MAR 2021 (Values in Cr)
Book Value / Share 25.48
ROE % -13.74
ROCE % 0.02
Total Debt to Total Equity 1.86
EBITDA Margin 17.94
Particulars MAR 2020 (Values in Cr)
Book Value / Share 29.03
ROE % -3.39
ROCE % -1.39
Total Debt to Total Equity 1.10
EBITDA Margin 13.74
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.65
Total Assets 61.95
Total Liabilities 61.95
Total Equity 22.21
Share Outstanding 6965000
Price to Book Ratio 1.33
Return on Assets (%) 1.79
Return on Capital (%) 2.16
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.33
Total Assets 60.36
Total Liabilities 60.36
Total Equity 21.10
Share Outstanding 6965263
Price to Book Ratio 1.10
Return on Assets (%) 5.31
Return on Capital (%) 6.24
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 64.41
Total Liabilities 64.41
Total Equity 17.90
Share Outstanding 6965263
Price to Book Ratio 0.99
Return on Assets (%) 0.32
Return on Capital (%) 0.39
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 66.38
Total Liabilities 66.38
Total Equity 17.74
Share Outstanding 6965263
Price to Book Ratio 0.31
Return on Assets (%) -3.92
Return on Capital (%) -4.83
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.42
Total Assets 65.00
Total Liabilities 65.00
Total Equity 20.22
Share Outstanding 6965263
Price to Book Ratio 0.28
Return on Assets (%) -5.97
Return on Capital (%) -7.76
Particulars MAR 2024 (Values in Cr)
Net Income 1.66
Cash from Operations 12.04
Cash from Investing -6.64
Cash from Financing -4.58
Net change in Cash 0.31
Free Cash Flow 16.39
Particulars MAR 2023 (Values in Cr)
Net Income 3.72
Cash from Operations 7.50
Cash from Investing -0.70
Cash from Financing -7.61
Net change in Cash -0.06
Free Cash Flow 11.44
Particulars MAR 2022 (Values in Cr)
Net Income 0.36
Cash from Operations 6.70
Cash from Investing -2.70
Cash from Financing -5.06
Net change in Cash 0.10
Free Cash Flow 7.68
Particulars MAR 2021 (Values in Cr)
Net Income -2.80
Cash from Operations 2.78
Cash from Investing -7.64
Cash from Financing 1.62
Net change in Cash -0.11
Free Cash Flow 10.33
Particulars MAR 2020 (Values in Cr)
Net Income -5.71
Cash from Operations 3.93
Cash from Investing -13.76
Cash from Financing 11.09
Net change in Cash 0.19
Free Cash Flow 5.37
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 76.74 13.41 100542.86 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 78.74 192.05 4.94 147.57 51.01 / 98.70
SHREE PACETRONIX LTD. 71.00 14.79 1.90 25.56 61.11 / 268.50
TRANSGENE BIOTEK LTD. 3.75 0.00 2.62 28.41 3.22 / 10.84
VIMTA LABS LIMITED 1037.40 37.94 6.72 2306.61 420.00 / 1183.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 83.66 12.27 100542.86 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 31.25 0.00 -16.74 23.34 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5584.95 29.60 6.27 6109.94 3750.00 / 6400.00

CHOKSI LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
120.85 1.46 redarrow
red-green-graph indicator
4 Bearish
12 Bullish
  • 5 Days 122.30
  • 26 Days 120.40
  • 10 Days 121.00
  • 50 Days 119.40
  • 12 Days 120.60
  • 100 Days 110.90
  • 20 Days 120.30
  • 200 Days 96.40
119.82 PIVOT

First Support

116.88

First Resistance

122.03

Second Support

114.67

Second Resistance

124.97

Third Support

111.73

Third Resistance

127.18

RSI

48.43

ADX

29.32

MACD

0.16

Williams % R

-37.45

Commodity Channel Index (CCI)

20.97

Date

2025-04-29

Week

6301.00

Same Day

3479.00

Month

13176.00

1 Year

0.78

3 Year

0.90

Over 1 Month

-3.17%

down

Over 1 Year

75.56%

down

Over 3 Months

-1.82%

down

Over 3 Years

61.07%

down

Over 6 Months

95.11%

down

Over 5 Years

65.06%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

CHOKSI LABORATORIES LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
66.58%
Promoter Holdings
31.48%
FII
1.93%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Sunil Choksi 523192.0 (7.51%) Shareholding of Promoter and Promoter Group
Vyangesh Choksi 447099.0 (6.42%) Shareholding of Promoter and Promoter Group
Sunil Kumar Choksi 400000.0 (5.74%) Shareholding of Promoter and Promoter Group
Khyati Choksi 301263.0 (4.33%) Shareholding of Promoter and Promoter Group
Choksi Holding Company Private Limited 300000.0 (4.31%) Shareholding of Promoter and Promoter Group
Sachin Seth 275719.0 (3.96%) Public Shareholding
Stela Choksi 220200.0 (3.16%) Shareholding of Promoter and Promoter Group
Gaurav Anand 200000.0 (2.87%) Public Shareholding
Emkey Commercial Company Limited 168792.0 (2.42%) Public Shareholding
Essence Dealmark Private Limited 152475.0 (2.19%) Public Shareholding
Shantanu Trivedi 150000.0 (2.15%) Public Shareholding
Timsy Kapoor 150000.0 (2.15%) Public Shareholding
Quest Laboratories Pvt.ltd. 142200.0 (2.04%) Public Shareholding
Nexus Global Opportunities Fund 134856.0 (1.94%) Public Shareholding
Asc Consulting Private Limited 86400.0 (1.24%) Public Shareholding
Alankit Imaginations Limited 83363.0 (1.2%) Public Shareholding
Nandlal Agarwal 78041.0 (1.12%) Public Shareholding
Kinjal Rajnikant Maniar 75938.0 (1.09%) Public Shareholding
Himika Choksi 1000.0 (0.01%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

CHOKSI LABORATORIES LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

CHOKSI LABORATORIES LTD. Share Price

Choksi Laboratories Limited, incorporated on 29 January, 1993 provides contract testing and analytical services. CLL is a group of research laboratories and consulting offices, offering analysis, calibration, pollution control, research and consultancy services to a broad spectrum of industries. The Company analyses, for its clients, or as a regulatory requirement pharmaceuticals, food and agricultural products, construction materials, chemicals, Calibration and environment Monitoring services.

The Company currently has facilities for analysis of over 1000 products and materials, with more being added every day. It provides calibration of production & quality control equipment with traceability to national / international standards. This means that the equipment are precise and therefore reducing the probability of end-product defects / rejects. This requires a detailed knowledge of the industry sector as well as the client's business processes. CLL has expertise in setting up in-house labs for a large number of clients, which provide consultancy, training & independent auditing for Quality Management Systems.

The Company started its unit at Vapi (Gujarat) and also got registered with FDA department during 2002. It started the laboratory at Chandigarh in 2005; thereafter the Goa Lab in 2011 and calibration of Bangalore operation from May 2011.

Parent organization Indian Private
NSE symbol [-]
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Choksi Laboratories Ltd?

Answer Field

The share price of Choksi Laboratories Ltd for NSE is ₹ 0.00 and for BSE is ₹ 120.85.

What is the Market Cap of Choksi Laboratories Ltd?

Answer Field

The market cap of Choksi Laboratories Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 84.20 Cr. as of now.

What is the 52 Week High and Low of Choksi Laboratories Ltd?

Answer Field

The 52 Week High and Low of Choksi Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 142.40 and ₹ 51.78.

How to Buy Choksi Laboratories Ltd share?

Answer Field

You can trade in Choksi Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Choksi Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 75.56%.

What is the Current Share Price of Choksi Laboratories Ltd?

Answer Field

Choksi Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 120.85 as on Apr 30 2025 03:07 PM.

What is the Market Cap of Choksi Laboratories Ltd Share?

Answer Field

The market cap of Choksi Laboratories Ltd for NSE ₹ 0.0 & for BSE ₹ 84.20 as on Apr 30 2025 03:07 PM.

What is the P/E Ratio of Choksi Laboratories Ltd Share?

Answer Field

As on Apr 30 2025 03:07 PM the price-to-earnings (PE) ratio for Choksi Laboratories Ltd share is 64.73.

What is the PB ratio of Choksi Laboratories Ltd Share?

Answer Field

As on Apr 30 2025 03:07 PM, the price-to-book (PB) ratio for Choksi Laboratories Ltd share is 33.03.

How to Buy Choksi Laboratories Ltd Share?

Answer Field

You can trade in Choksi Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Choksi Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Choksi Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Choksi Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|